Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.5K Buy
10,018
+245
+3% +$766 ﹤0.01% 2584
2026
Q1
$28.5K Buy
9,773
+881
+10% +$2.52K ﹤0.01% 2525
2025
Q4
$22K Buy
8,892
+3,468
+64% +$8.26K ﹤0.01% 2556
2025
Q3
$12.1K Sell
5,424
-530
-9% -$1.21K ﹤0.01% 2790
2025
Q2
$14.3K Buy
5,954
+1,234
+26% +$3K ﹤0.01% 2633
2025
Q1
$11K Buy
4,720
+2,785
+144% +$5.57K ﹤0.01% 2707
2024
Q4
$3.58K Sell
1,935
-1,680
-46% -$3.72K ﹤0.01% 3040
2024
Q3
$8.82K Sell
3,615
-5
-0.1% -$11 ﹤0.01% 2514
2024
Q2
$7.42K Buy
3,620
+2,764
+323% +$6.29K ﹤0.01% 2396
2024
Q1
$2.12K Sell
856
-304
-26% -$792 ﹤0.01% 2728
2023
Q4
$3.04K Buy
+1,160
New +$3.13K ﹤0.01% 2432

Other funds holding ABEV

GAMMA Investing's ABEV Position: Q2 2026 in Review

GAMMA Investing increased its Ambev (ABEV) stake by 2.5% in Q2 2026, buying an estimated $766 and bringing the position to 10,018 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

GAMMA Investing first reported a position in ABEV in Q4 2023 and has held it in 11 quarters since. 49 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • GAMMA Investing held 10,018 shares of Ambev worth $31.5K as of Q2 2026.
  • GAMMA Investing bought 245 Ambev shares in Q2 2026, an estimated $766.
  • Ambev made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2584 holding.
  • GAMMA Investing first reported a position in Ambev in Q4 2023 and has held it in 11 quarters since.
  • 49 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.